A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2001
12/04/2001	CA2139948C Targeting somatic gene therapy to joints
12/04/2001	CA2124763C Lipase inhibitor derived from a defatted rice germ
12/04/2001	CA2117581C Protocadherin, their antibodies and uses
12/04/2001	CA2062729C Interferon purification process
12/04/2001	CA2049873C Anticoagulant combination of laci and sulfated polysaccharides
12/04/2001	CA2046880C Substituted alkylamide derivatives of teicoplanin
12/04/2001	CA2027635C Erythropoietin isoforms
12/04/2001	CA2024253C Entities for cancer therapy
12/01/2001	CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/29/2001	WO2001090758A2 Diagnosis of alzheimer's disease ldl receptor protein-1
11/29/2001	WO2001090745A2 Determination of naaladase inhibitors
11/29/2001	WO2001090421A2 Method of detecting inflammatory lung disorders
11/29/2001	WO2001090391A2 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
11/29/2001	WO2001090379A1 Novel polypeptide - a human basophil granule protein 22.55 and polynucleotide encoding it
11/29/2001	WO2001090377A1 Novel polypeptide - a human von hippel lindau tumour suppressor gene 14 and polynucleotide encoding it
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090369A1 A novel polypeptide, a human n-acetylgalactosamine transferase -28 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090368A1 A novel polypeptide, a human protein 9 containing glutamine transferase active site and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090367A1 A novel polypeptide, a human aldehyde/ketone reductase 9.2 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090366A2 Human polynucleotides and polypeptides encoded thereby
11/29/2001	WO2001090361A2 Modulation of inflammation by protease-treated mcp-3 chemokine
11/29/2001	WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090358A2 Mammalian receptor proteins; related reagents and methods
11/29/2001	WO2001090354A1 Treatment of cancer and neurological diseases
11/29/2001	WO2001090351A1 A novel polypeptide, a human interleukin binding factor 13.31 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090350A1 A novel polypeptide, a human beta-microtubulin folding co-factor c-9 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090349A1 A novel polypeptide, a human zinc finger protein 12 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090348A1 A novel polypeptide, a human myoglobulin heavy chain 11 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090345A2 Methods and compositions for enhancing the delivery of a nucleic acid to a cell
11/29/2001	WO2001090342A2 Genetic engineering of vascular grafts to resist disease
11/29/2001	WO2001090341A1 Antisense modulation of pten expression
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090333A2 Recombinant bacterial phytases and uses thereof
11/29/2001	WO2001090332A2 Dna repair polypeptides and methods of use
11/29/2001	WO2001090331A2 C1 bacteriophage lytic system
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001	WO2001090325A2 50365, a hexokinase family member and uses thereof
11/29/2001	WO2001090320A2 A novel helicase family member and uses thereof
11/29/2001	WO2001090318A2 Regulation of human polyamine oxidase-like enzyme
11/29/2001	WO2001090309A2 Peptides that stimulate mycobacterial growth
11/29/2001	WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001	WO2001090300A2 Snap back stealth oligonucleotide
11/29/2001	WO2001090198A1 Multicomponent conjugates which bind to target molecules and stimulate cell lysis
11/29/2001	WO2001090197A1 Synthetic peptides and uses therefore
11/29/2001	WO2001090192A2 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	WO2001090189A2 G-protein coupled receptor org3.
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090185A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001	WO2001090181A1 A novel polypeptide -human b cell protein tyrosine kinase 13 and a polynucleotide sequence encoding the same
11/29/2001	WO2001090178A1 A novel polypeptide - human dihydroorotase 11 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090177A1 A novel polypeptide, a human natural killer cell enhancing factor b13.64 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090176A1 A novel polypeptide - human keratin 45.87 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090174A1 A novel polypeptide-human peroxisome fatty acid acetyl-coa oxidase 46.97 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090173A1 A novel polypeptide, a molecular chaperone cpn60 protein 10 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090171A1 A novel polypeptide-human robosomal sii protein 12 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090170A1 A novel polypeptide, a human neural cell adhesion protein 31 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090169A1 A novel polypeptide- human proliferating cell nuclear antigen (pcna) 13 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090168A1 A novel polypeptide, a human atp dependent-uncoiling enzyme protein 10 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090167A1 A novel polypeptide, a human zinc finger protein 11 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090165A1 A novel polypeptide-homo laminin protein b2 chain 13 and polynucleotide encoding said polypeptide
11/29/2001	WO2001090160A2 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
11/29/2001	WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001	WO2001090157A2 98p7c3: homeodomain protein highly expressed in various cancers
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	WO2001090151A2 Human receptor proteins; related reagents and methods
11/29/2001	WO2001090150A2 G protein-coupled receptors from human clone '26908' and uses thereof
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090146A2 57256 and 58289, human transporters and uses thereof
11/29/2001	WO2001090145A2 57805, a human cadherin family member and uses thereof
11/29/2001	WO2001090144A2 Vip-related peptides for the treatment of sexual disorders in women
11/29/2001	WO2001090142A2 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS
11/29/2001	WO2001090140A1 Peptoids as ligands for melanocortin receptors
11/29/2001	WO2001090139A2 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	WO2001090132A1 A novel peptide-human zinc finger protein 9 and the polynucleotide coding this novel peptide
11/29/2001	WO2001090095A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001089583A2 Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases
11/29/2001	WO2001089582A1 Preventives and remedies for pulmonary hypertension
11/29/2001	WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001	WO2001089580A1 Systemic and cardiovascular transduction with lentiviral vectors
11/29/2001	WO2001089570A2 Combination of growth hormone secretagogues and antidepressants
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	WO2001089566A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
11/29/2001	WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089557A2 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001	WO2001089556A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
11/29/2001	WO2001089555A1 Compositions with anti-proliferative activities and methods for use thereof
11/29/2001	WO2001089554A2 Treatment of acute coronary syndrome with glp-1
11/29/2001	WO2001089553A1 Enhanced triglyceride digestion in a deficiency of bile salts
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089551A1 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
11/29/2001	WO2001089550A2 Use of ciliary neurotrophic factor
11/29/2001	WO2001089549A2 Therapeutic uses of il-1 receptor antagonist
11/29/2001	WO2001089548A2 Pharmaceutical use of fibulin-1

1 ... 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 ... 3163